Indian Pharmacopoeia Commission Signs Three MoUs

The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, has entered into Memoranda of Understanding (MoUs) with the Goa State Pharmacy Council (GSPC), Quality Council of India (QCI), and HLL Infra Tech Services Limited (HITES), to strengthen drug safety, quality assurance, and capacity-building initiatives in the country.

The MoU between IPC and GSPC provides a structured framework for collaboration in the areas of pharmacovigilance, rational use of medicines, and professional development of pharmacists in the State of Goa. The collaboration envisages promotion of the National Formulary of India among registered pharmacists, strengthening of adverse drug reaction (ADR) reporting mechanisms under the Pharmacovigilance Programme of India (PvPI), conduct of training programmes, workshops, and continuing education activities, and facilitation of awareness initiatives related to drug safety, pharmacopoeial standards, and sustainable pharmacopoeia. The MoU also aims to support the establishment and strengthening of ADR Monitoring Centres and enhance systematic reporting and documentation practices across healthcare facilities in the state.

The Joint Secretary, Ministry of Health and Family Welfare (MoHFW), Harsh Mangla, emphasized the critical role of the regulatory sector in the effective implementation of primary and secondary healthcare across the country. Shri Mangla congratulated Dr. V. Kalaiselvan, Secretary-cum-Scientific Director (IPC), and the representatives of the Goa State Pharmacy Council and NABET, QCI, addressing the gathering on the occasion of the MoU signing. He described the MoU as a significant starting point for institutional partnership, while underscoring that sustained efforts would be required to achieve long-term public health goals.(updated on 9th feb 2026)